MADISON, Wis. (AP) _ Exact Sciences Corp. (EXAS) on Tuesday reported a loss of $83.1 million in its first quarter.
The Madison, Wisconsin-based company said it had a loss of 66 cents per share.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 64 cents per share.
The molecular diagnostics company posted revenue of $162 million in the period, which beat Street forecasts. Five analysts surveyed by Zacks expected $153.4 million.
Exact Sciences expects full-year revenue in the range of $725 million to $740 million.
Exact Sciences shares have risen 56% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $98.55, a climb of 97% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EXAS at https://www.zacks.com/ap/EXAS